Age-related macular degeneration: Genetics and biology coming together

Annual Review of Genomics and Human Genetics

Volumn 15, Issue , 2014, Pages 151-171

  Fritsche, Lars G ^a   Fariss, Robert N ^b   Stambolian, Dwight ^d   Abecasis, Gonçalo R ^a   Curcio, Christine A ^e   Swaroop, Anand ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Biological Imaging Core ^*  (United States)

^c NATIONAL EYE INSTITUTE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

blindness; complex disease; genetic susceptibility; neurodegeneration; retina

Indexed keywords

AGING; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LOAD; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; HEREDITY; HERITABILITY; HISTOPATHOLOGY; HUMAN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHOTOOXIDATION; PHOTORECEPTOR; PHOTOTOXICITY; PIGMENT EPITHELIUM; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; REVIEW; RNA INTERFERENCE; HAPLOTYPE; MACULAR DEGENERATION; MUTATION; PATHOLOGY; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

COMPLEMENT FACTOR H;

COMPLEMENT FACTOR H; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; MACULAR DEGENERATION; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84906858173     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-090413-025610     Document Type: Review

References (122)

1. 1000 Genomes Proj. Consort. 2012. An integrated map of genetic variation from 1, 092 human genomes. Nature 491:56-65
2. Ambati J, Fowler BJ. 2012. Mechanisms of age-related macular degeneration. Neuron 75:26-39
3. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, et al. 2010. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res. 29:95-112
4. Awh CC, Lane AM, Hawken S, Zanke B, Kim IK. 2013. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Ophthalmology 120:2317-23
5. Buitendijk GH, Rochtchina E, Myers C, van Duijn CM, Lee KE, et al. 2013. Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium. Ophthalmology 120:2644-55
6. Canter JA, Olson LM, Spencer K, Schnetz-Boutaud N, Anderson B, et al. 2008. Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration. PLoS ONE 3:e2091
7. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, et al. 2010.GeneticvariantsnearTIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 107:7401-6
8. Chew EY, Clemons TE, Agron E, Sperduto RD, Sangiovanni JP, et al. 2013. Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology 120:1604-11
9. Chong NH, Keonin J, Luthert PJ, Frennesson CI, Weingeist DM, et al. 2005. Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. Am. J. Pathol. 166:241-51
10. Collins FS. 2011. Faces of the genome. Science 331:546
11. Conley YP, Jakobsdottir J, Mah T, Weeks DE, Klein R, et al. 2006. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum. Mol. Genet. 15:3206-18
12. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, et al. 2002. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 99:14682-87
13. Curcio CA, Johnson M. 2013. Structure, function, and pathology of Bruch's membrane. In Retina, Vol. 1, Part 2: Basic Science and Translation to Therapy, ed. SJ Ryan, AP Schachat, CP Wilkinson, DR Hinton, S Sadda, P Wiedemann, pp. 466-81. London: Elsevier. 5th ed.
14. Curcio CA, Johnson M, Huang JD, Rudolf M. 2009. Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog. Retin. Eye Res. 28:393-422
15. Curcio CA, Johnson M, Rudolf M, Huang JD. 2011. The oil spill in ageing Bruch membrane. Br. J. Ophthalmol. 95:1638-45
16. Curcio CA, Messinger JD, Sloan KR, McGwin G Jr, Medeiros NE, Spaide RF. 2013. Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina 33:265-76
17. Curcio CA, Millican CL, Bailey T, Kruth HS. 2001. Accumulation of cholesterol with age in human Bruch's membrane. Investig. Ophthalmol. Vis. Sci. 42:265-74
18. Curcio CA, Owsley C, Jackson GR. 2000. Spare the rods, save the cones in aging and age-related maculopathy. Investig. Ophthalmol. Vis. Sci. 41:2015-18
19. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. 1990. Human photoreceptor topography. J. Comp. Neurol. 292:497-523
20. Day S, Acquah K, Lee PP, Mruthyunjaya P, Sloan FA. 2011. Medicare costs for neovascular age-related macular degeneration, 1994-2007. Am. J. Ophthalmol. 152:1014-20
21. Delori FC, Goger DG, Dorey CK. 2001. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Investig. Ophthalmol. Vis. Sci. 42:1855-66
22. Do R, Kathiresan S, Abecasis GR. 2012. Exome sequencing and complex disease: practical aspects of rare variant association studies. Hum. Mol. Genet. 21:R1-9
23. Edwards AO, Lee SJ, Fridley BL, Tosakulwong N. 2008. Density of common complex ocular traits in the aging eye: analysis of secondary traits in genome-wide association studies. PLoS ONE 3:e2510
24. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. 2005. Complement factor H polymorphism and age-related macular degeneration. Science 308:421-24
25. Eldred GE, Miller GV, Stark WS, Feeney-Burns L. 1982. Lipofuscin: resolution of discrepant fluorescence data. Science 216:757-59
26. Fariss RN, Apte SS, Olsen BR, Iwata K, Milam AH. 1997. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am. J. Pathol. 150:323-28
27. Feeney-Burns L, Ellersieck MR. 1985. Age-related changes in the ultrastructure of Bruch's membrane. Am. J. Ophthalmol. 100:686-97
28. Feero WG, Guttmacher AE, Collins FS. 2010. Genomic medicine-an updated primer. N. Engl. J. Med. 362:2001-11
29. Ferris FL III, Davis MD, Clemons TE, Lee LY, Chew EY, et al. 2005. A simplified severity scale for age-related macular degeneration: AREDS report no. 18. Arch. Ophthalmol. 123:1570-74
30. Ferris FL III, Wilkinson CP, Bird A, Chakravarthy U, Chew E, et al. 2013. Clinical classification of age-related macular degeneration. Ophthalmology 120:844-51
31. Fisher SA, Abecasis GR, Yashar BM, Zareparsi S, Swaroop A, et al. 2005. Meta-analysis of genome scans of age-related macular degeneration. Hum. Mol. Genet. 14:2257-64
32. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, et al. 2004. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 122:564-72
33. Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, et al. 2013. Seven new loci associated with age-related macular degeneration. Nat. Genet. 45:433-39
34. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, et al. 2006. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38:458-62
35. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. 2005. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102:7227-32
36. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. 2001. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res. 20:705-32
37. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. 2005. Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419-21
38. Hammond CJ, Webster AR, Snieder H, Bird AC, Gilbert CE, Spector TD. 2002. Genetic influence on early age-related maculopathy: a twin study. Ophthalmology 109:730-36
39. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. 2003. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60:1119-22
40. Helgason H, Sulem P, Duvvari MR, Luo H, Thorleifsson G, et al. 2013. A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration. Nat. Genet. 45:1371-74
41. Hoeijmakers JH. 2009. DNA damage, aging, and cancer. N. Engl. J. Med. 361:1475-85
42. Holliday EG, Smith AV, Cornes BK, Buitendijk GH, Jensen RA, et al. 2013. Insights into the genetic architecture of early stage age-related macular degeneration: a genome-wide association study meta-analysis. PLoS ONE 8:e53830
43. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, et al., eds. 2012. SEER cancer statistics review, 1975- 2009 ( vintage 2009 populations). Surveill. Epidemiol. End Results Program, updated Aug. 20, Natl. Cancer Inst., Bethesda, MD. http://seer.cancer.gov/csr/1975-2009-pops09
44. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH. 2000. A potential role for immune complex pathogenesis in drusen formation. Exp. Eye Res. 70:441-49
45. Jones MM, Manwaring N, Wang JJ, Rochtchina E, Mitchell P, Sue CM. 2007. Mitochondrial DNA haplogroups and age-related maculopathy. Arch. Ophthalmol. 125:1235-40
46. Kalf RR, Mihaescu R, Kundu S, de Knijff P, Green RC, Janssens AC. 2013. Variations in predicted risks in personal genome testing for common complex diseases. Genet. Med. 16:85-91
47. Kamei M, Hollyfield JG. 1999. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 40:2367-75
48. Kanda A, Chen W, Othman M, Branham KE, Brooks M, et al. 2007. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc. Natl. Acad. Sci. USA 104:16227-32
49. Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB, et al. 2010. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 117:921-27
50. Klein BE, Klein R, Lee KE, Moore EL, Danforth L. 2001. Risk of incident age-related eye diseases in people with an affected sibling: the Beaver Dam Eye Study. Am. J. Epidemiol. 154:207-11
51. Klein ML, Mauldin WM, Stoumbos VD. 1994. Heredity and age-related macular degeneration: observations in monozygotic twins. Arch. Ophthalmol. 112:932-37
52. Klein R, Cruickshanks KJ, Nash SD, Krantz EM, Nieto FJ, et al. 2010. The prevalence of age-related macular degeneration and associated risk factors. Arch. Ophthalmol. 128:750-58
53. Klein R, Klein BE, Jensen SC, Mares-Perlman JA, Cruickshanks KJ, Palta M. 1999. Age-related mac-ulopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology 106:1056-65
54. Klein R, Klein BE, Knudtson MD, Wong TY, Cotch MF, et al. 2006. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis. Ophthalmology 113:373-80
55. Klein R, Li X, Kuo JZ, Klein BE, Cotch MF, et al. 2013. Associations of candidate genes to age-related macular degeneration among racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis. Am. J. Ophthalmol. 156:1010-20
56. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. 2005. Complement factor H polymorphism in age-related macular degeneration. Science 308:385-89
57. Kondo N, Bessho H, Honda S, Negi A. 2011. Complement factor H Y402H variant and risk of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 118:339-44
58. Lander ES. 2011. Initial impact of the sequencing of the human genome. Nature 470:187-97
59. LaVail MM. 1983. Outer segment disc shedding and phagocytosis in the outer retina. Trans. Ophthalmol. Soc. UK 103:397-404
60. Lesnefsky EJ, Hoppel CL. 2006. Oxidative phosphorylation and aging. Ageing Res. Rev. 5:402-33
61. Li M, Atmaca-Sonmez P, Othman M, Branham KE, Khanna R, et al. 2006. CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat. Genet. 38:1049-54
62. Luo DG, Xue T, Yau KW. 2008. How vision begins: an odyssey. Proc. Natl. Acad. Sci. USA 105:9855-62
63. Ma W, Zhao L, Wong WT. 2012. Microglia in the outer retina and their relevance to pathogenesis of age-related macular degeneration. Adv. Exp. Med. Biol. 723:37-42
64. Marneros AG. 2013. NLRP3 inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration. Cell Rep. 4:945-58
65. McKibbin M, Ali M, Bansal S, Baxter PD, West K, et al. 2012. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration. Br. J. Ophthalmol. 96:208-12
66. McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA. 2009. Relationship between RPE and choriocapillaris in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 50:4982-91
67. Meleth AD, Wong WT, Chew EY. 2011. Treatment for atrophic macular degeneration. Curr. Opin. Ophthalmol. 22:190-93
68. Meyers SM, Greene T, Gutman FA. 1995. A twin study of age-related macular degeneration. Am. J. Ophthalmol. 120:757-66
69. Miller JW. 2013. Age-related macular degeneration revisited-piecing the puzzle: the LXIX Edward Jackson memorial lecture. Am. J. Ophthalmol. 155:1-35.e13
70. Moreira EF, Larrayoz IM, Lee JW, Rodriguez IR. 2009. 7-Ketocholesterol is present in lipid deposits in the primate retina: potential implication in the induction of VEGF and CNV formation. Investig. Ophthalmol. Vis. Sci. 50:523-32
71. Mullins RF, Russell SR, Anderson DH, Hageman GS. 2000. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 14:835-46
72. Natl. Eye Inst. 2014. Age-related macular degeneration (AMD). Natl. Eye Inst., Bethesda, MD. http://www.nei.nih.gov/eyedata/amd.asp
73. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, et al. 2010. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc. Natl. Acad. Sci. USA 107:7395-400
74. Priya RR, Chew EY, Swaroop A. 2012. Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management. Ophthalmology 119:2526-36
75. Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK, et al. 2011. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat. Genet. 43:1232-36
76. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, et al. 2004. Global data on visual impairment in the year 2002. Bull. World Health Organ. 82:844-51
77. Ridge KD, Abdulaev NG, Sousa M, Palczewski K. 2003. Phototransduction: crystal clear. Trends Biochem. Sci. 28:479-87
78. Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, et al. 2005. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum. Mol. Genet. 14:3227-36
79. Rodriguez IR, Larrayoz IM. 2010. Cholesterol oxidation in the retina: implications of 7KCh formation in chronic inflammation and age-related macular degeneration. J. Lipid Res. 51:2847-62
80. Rohrer B, Coughlin B, Kunchithapautham K, Long Q, Tomlinson S, et al. 2011. The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascular-ization. Mol. Immunol. 48:e1-8
81. Rosenfeld PJ, Shapiro H, Tuomi L, Webster M, Elledge J, et al. 2011. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology 118:523-30
82. Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. 2012. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119:571-80
83. Rudolf M, Clark ME, Chimento MF, Li CM, Medeiros NE, Curcio CA. 2008. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Investig. Ophthalmol. Vis. Sci. 49:1200-9
84. SanGiovanni JP, Arking DE, Iyengar SK, Elashoff M, Clemons TE, et al. 2009. Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS ONE 4:e5508
85. Sarks SH, Arnold JJ, Killingsworth MC, Sarks JP. 1999. Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br. J. Ophthalmol. 83:358-68
86. Schleicher M, Weikel K, Garber C, Taylor A. 2013. Diminishing risk for age-related macular degeneration with nutrition: a current view. Nutrients 5:2405-56
87. Seddon JM, Ajani UA, Mitchell BD. 1997. Familial aggregation of age-related maculopathy. Am. J. Ophthalmol. 123:199-206
88. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. 2005. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch. Ophthalmol. 123:321-27
89. Seddon JM, Reynolds R, Yu Y, Rosner B. 2013. Validation of a prediction algorithm for progression to advanced macular degeneration subtypes. JAMA Ophthalmol. 131:448-55
90. Seddon JM, Yu Y, Miller EC, Reynolds R, Tan PL, et al. 2013. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat. Genet. 45:1366-70
91. Sene A, Khan AA, Cox D, Nakamura RE, Santeford A, et al. 2013. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 17:549-61
92. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, et al. 2001. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108:697-704
93. So HC, Li M, Sham PC. 2011. Uncovering the total heritability explained by all true susceptibility variants in a genome-wide association study. Genet. Epidemiol. 35:447-56
94. Sobrin L, Reynolds R, Yu Y, Fagerness J, Leveziel N, et al. 2011. ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am. J. Ophthalmol. 151:345-52.e3
95. Sohal RS, Weindruch R. 1996. Oxidative stress, caloric restriction, and aging. Science 273:59-63
96. Sparrow JR, Boulton M. 2005. RPE lipofuscin and its role in retinal pathobiology. Exp. Eye Res. 80:595-606
97. Sparrow JR, Fishkin N, Zhou J, Cai B, Jang YP, et al. 2003. A2E, a byproduct of the visual cycle. Vis. Res. 43:2983-90
98. Spraul CW, Grossniklaus HE. 1997. Characteristics of drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch. Ophthalmol. 115:267-73
99. Spraul CW, Lang GE, Grossniklaus HE. 1996. Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epitheliumineyes with age-related macular degeneration.Investig. Ophthalmol. Vis. Sci. 37:2724-35
100. Stadtman ER. 1992. Protein oxidation and aging. Science 257:1220-24
101. Strauss O. 2005. The retinal pigment epithelium in visual function. Physiol. Rev. 85:845-81
102. Strunnikova NV, Maminishkis A, Barb JJ, Wang F, Zhi C, et al. 2010. Transcriptome analysis and molecular signature of human retinal pigment epithelium. Hum. Mol. Genet. 19:2468-86
103. Swaroop A, Branham KE, Chen W, Abecasis G. 2007. Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum. Mol. Genet. 16:R174-82
104. Swaroop A, Chew EY, Rickman CB, Abecasis GR. 2009. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu. Rev. Genomics Hum. Genet. 10:19-43
105. Swaroop A, Sieving PA. 2013. The golden era of ocular disease gene discovery: race to the finish. Clin. Genet. 84:99-101
106. Tarallo V, Hirano Y, Gelfand BD, Dridi S, Kerur N, et al. 2012. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149:847-59
107. Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J, et al. 2006. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum. Mol. Genet. 15:2784-90
108. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. 2005. Smoking and age-related macular degeneration: a review of association. Eye 19:935-44
109. Tikellis G, Robman LD, Dimitrov P, Nicolas C, McCarty CA, Guymer RH. 2007. Characteristics of progression of early age-related macular degeneration: the cardiovascular health and age-related maculopathy study. Eye 21:169-76
110. Tilleul J, Richard F, Puche N, Zerbib J, Leveziel N, et al. 2013. Genetic association study of mitochondrial polymorphisms in neovascular age-related macular degeneration. Mol. Vis. 19:1132-40
111. Tserentsoodol N, Gordiyenko NV, Pascual I, Lee JW, Fliesler SJ, Rodriguez IR. 2006. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol. Vis. 12:1319-33
112. Tserentsoodol N, Sztein J, Campos M, Gordiyenko NV, Fariss RN, et al. 2006. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol. Vis. 12:1306-18
113. van de Ven JP, Nilsson SC, Tan PL, Buitendijk GH, Ristau T, et al. 2013. A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat. Genet. 45:813-17
114. Wangsa-Wirawan ND, Linsenmeier RA. 2003. Retinal oxygen: fundamental and clinical aspects. Arch. Ophthalmol. 121:547-57
115. Winkler BS, Boulton ME, Gottsch JD, Sternberg P. 1999. Oxidative damage and age-related macular degeneration. Mol. Vis. 5:32
116. Wong-Riley MT. 2010. Energy metabolism of the visual system. Eye Brain 2:99-116
117. Wright S. 1934. An analysis of variability in number of digits in an inbred strain of guinea pigs. Genetics 19:506-36
118. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, et al. 2007. Complement C3 variant and the risk of age-related macular degeneration. N. Engl. J. Med. 357:553-61
119. Young RW. 1969. The organization of vertebrate photoreceptor cells. UCLA Forum Med. Sci. 8:177-210
120. Zareparsi S, Branham KE, Li M, Shah S, Klein RJ, et al. 2005. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am. J. Hum. Genet. 77:149-53
121. Zhan X, Larson DE, Wang C, Koboldt DC, Sergeev YV, et al. 2013. Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat. Genet. 45:1375-79
122. Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF. 2010. Prevalence and significance of sub-retinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology 117:1775-81